1. Noone AM, Howlader N, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin K (2018) SEER cancer statistics review, 1975–2015. National Cancer Institute.
https://seer.cancer.gov/csr/1975_2015/
, based on November 2017 SEER data submission, posted to the SEER web site, April 2018, Bethesda, MD
2. National Comprehensive Cancer Network (2018) NCCN Clinical practice guidelines in oncology: breast cancer. V.1.2018.
http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf
3. Sprague BL, McLaughlin V, Hampton JM, Newcomb PA, Trentham-Dietz A (2013) Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study. Breast Cancer Res Treat 141(1):145–154
4. Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ (2011) Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst 103(2):92–104
5. Falk RS, Hofvind S, Skaane P, Haldorsen T (2011) Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Breast Cancer Res Treat 129(3):929–938